Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
187.10    0.30 (0.16%)
Bid:
185.70
Ask:
186.20
Spread: 0.50 (0.269%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Board Appointment and Retirement

18 Aug 2022 07:00

RNS Number : 3906W
B&M European Value Retail S.A.
18 August 2022
 

 

18 August 2022

B&M European Value Retail S.A.

Board Appointment and Retirement

 

B&M European Value Retail S.A. (the "Company") announces the following Board changes.

 

Oliver Tant is to be appointed, subject to shareholder approval, as a Non-Executive Director of the Company with effect from 1 November 2022 when he will also join the Audit & Risk and Nomination Committees. At the conclusion of the Company's AGM in July 2023, it is intended that Oliver will succeed Ron McMillan as the Chair of the Audit & Risk Committee. Ron will by then have served over nine years as a Non-Executive Director and accordingly will be retiring from the Board.

 

Oliver Tant was Chief Financial Officer ("CFO") of FTSE 30 global consumer and international tobacco company Imperial Brands PLC from 2013 to 2021. Oliver had responsibility for the full range of finance functions along with the corporate development, legal, science, IT and procurement teams. During his time at Imperial, Oliver made a significant contribution to the transformation and development of the business.

 

Oliver is currently a Non-Executive Director and Audit Committee Chair designate of Redrow plc. Oliver is also currently working with Brookfield Asset Management where he is providing financial consulting services to their portfolio company Modulaire Group.

 

Prior to joining Imperial, Oliver spent over 30 years with KPMG. He was a partner from 1994 (covering audit, transaction and advisory services) and from 2005 was co-lead of the Financial Advisory business. From 2009 to 2012 Oliver was UK Head of Audit. Oliver also served on KPMG's international executive committee for a period of four years.

 

For the last four years Ron McMillan has also held the role of Senior Independent Director. A separate announcement will be made in due course in relation to the succession plan for this role.

 

 

Peter Bamford, Chairman, said

 "I am delighted that Oliver has agreed to join the Board of B&M. His previous roles at Imperial Brands and KPMG give the combined experience of a Big Four audit partner with eight years as CFO of a FTSE 100 business. I am sure that he will add a great deal of value both as a Non-Executive Director and in his future role as Audit & Risk Committee Chair.

 

Ron has been an outstanding Chair of the Audit & Risk Committee and has played a critical role in the successful transition of B&M from IPO in 2014 to a FTSE 100 company. However, it is now right that we plan for his succession. On behalf of the Board, I would like to thank Ron for his service to B&M and look forward to working with him over the remaining period of his directorship."

With regard to Oliver Tant's appointment to the Board on 1 November 2022, as there is currently no vacancy in the office of a Director of the Company, in accordance with Luxembourg law, his appointment is required to be approved by a resolution of shareholders at a general meeting of the Company. Accordingly, an Ordinary General Meeting of shareholders is to be convened during October 2022 (the "Meeting") for that purpose. Subject to his appointment being approved at the Meeting, it will take effect on 1 November 2022. Further announcements will be made to confirm when the notice of the Meeting has been despatched to shareholders, and also following the Meeting to confirm the outcome of the resolution to approve the appointment.

 

The Company makes this announcement in accordance with LR 9.6.11R of the Listing Rules. There are no other matters to be disclosed under LR9.6.13R in relation to the appointment of Oliver Tant.

 

Enquiries

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive Officer

Alex Russo, Chief Financial Officer

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland

Sam Cartwright

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFIDTSIDLIF
Date   Source Headline
18th Jun 202610:00 amRNSBoard Retirement
18th Jun 202610:00 amRNSPublication of Annual Report and Notice of AGM
16th Jun 202612:00 pmRNSDirector/PDMR Shareholding
11th Jun 20261:00 pmRNSTiming of Q1 FY27 Trading Statement
3rd Jun 20267:00 amRNSFY26 Preliminary Results
10th Apr 20269:00 amRNSDirectorate Changes and Leadership Appointments
26th Mar 20264:45 pmRNSMajor Holding(s) in Company - TR1
24th Mar 20264:30 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:31 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:30 pmRNSMajor Holding(s) in Company - TR1
9th Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20268:00 amRNSAdmission of B&M Jersey Shares
2nd Mar 20268:00 amRNSReadmission - B&M European Value Retail S.A.
27th Feb 20264:48 pmRNSMigration Completion
25th Feb 202611:00 amRNSPublication of a Prospectus - Migration
24th Feb 20261:00 pmRNSDirector/PDMR Shareholding
22nd Jan 20262:00 pmRNSUpdate statement on 2025 AGM voting results
22nd Jan 20267:00 amRNSQ3 FY26 Trading Statement
15th Jan 20269:00 amRNSBlock listing Interim Review
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
4th Dec 202510:00 amRNSMajor Holding in Company - TR1
28th Nov 202511:00 amRNSMajor Holding in Company - TR1
26th Nov 20259:30 amRNSMajor Holding in Company TR1
24th Nov 20252:30 pmRNSMajor Holding in Company- TR1
20th Nov 20254:00 pmRNSCEO Purchase of shares
20th Nov 202511:00 amRNSCEO Purchase of Shares
19th Nov 20259:01 amRNSCEO Purchase of Shares
19th Nov 20259:00 amRNSMajor Holding in Company TR1
18th Nov 202511:00 amRNSCEO Purchase of Shares
18th Nov 202510:58 amRNSMajor Holding in Company- TR1
14th Nov 20253:30 pmRNSMajor Holding in Company TR1
13th Nov 20257:00 amRNSFY26 Interim Results
4th Nov 20256:05 pmRNSMajor Holding in Company TR1
4th Nov 20256:00 pmRNSMajor Holding in Company TR1
30th Oct 20259:00 amRNSMajor Holding in Company TR1
28th Oct 20254:00 pmRNSMajor Holding in Company TR1
27th Oct 20251:01 pmRNSMajor Holding in Company TR1
27th Oct 20251:00 pmRNSMajor Holding in Company TR1
20th Oct 20257:00 amRNSUpdate on FY26 Guidance and Directorate Change
13th Oct 20253:30 pmRNSInformation to shareholders: statutory migration
7th Oct 20257:00 amRNSFY26 H1 Trading and Operational Update
22nd Sep 202511:30 amRNSCEO Purchase of Shares
18th Sep 20256:00 pmRNSDirector/PDMR Shareholding
15th Sep 20254:34 pmRNSCEO Purchase of Shares
11th Sep 202511:00 amRNSCEO Purchase of Shares
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20254:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.